Washington, D.C. — As Congress and the White House look to address the healthcare affordability crisis facing employers and consumers, the Coalition Against Surprise Medical Billing (CASMB) today launched its latest ad, “Real Relief,” urging lawmakers and the Trump administration to tackle the abuse and misuse of the No Surprises Act’s independent dispute resolution (IDR) process, particularly by certain private equity-backed providers.
The latest ad underscores the exorbitant cost burden of IDR, approximately $22.4 billion from 2022 through 2025. The Congressional Budget Office and many researchers have pointed to the outsized impact of certain private equity-backed providers relying on IDR as a “go-to” mechanism for payment disputes, undermining efforts to expand access to in-network care and safeguard consumers from healthcare cost increases.
A recent analysis by The ERISA Industry Committee (ERIC) found that IDR awards alone add up to 6 percent to overall healthcare cost trends and that some employers have faced more than $10 million in unanticipated IDR exposure within a single year.
As part of this latest advertising push, CASMB calls on policymakers and the Trump administration to take legislative and regulatory action to rein in IDR fraud, waste, and abuse contributing to a flood of ineligible claims and misaligned incentives that drive up premiums and healthcare costs.
IDR reform has broad support from across the healthcare system, including more than 60 consumer and patient organizations, leading employers, corporations, unions, and policy experts and other stakeholders that want to see an end to the provider-led abuse and misuse of the arbitration process.
To learn more, visit stopsurprisebillingnow.com/arbitration.
Recent Comments